Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice.
Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice.
复制标题
DOI:
10.1097/hjh.0000000000002809
复制
发表时间:
2021-08-01
影响因子:
4.9
通讯作者:
Li N
中科院分区:
文献类型:
--
作者:
Hu G;Zhu Q;Wang W;Xie D;Chen C;Li PL;Ritter JK;Li N
We have previously reported that renal medullary sphingosine-1-phosphate (S1P) regulates sodium excretion via the S1P type-1 receptor (S1PR1). As S1PR1 is predominantly expressed in collecting ducts (CD), the present study tested the hypothesis that the CD-S1PR1 pathway plays a critical role in sodium excretion and contributes to salt-sensitive hypertension. CD-specific S1PR1 knockout (KO) mice were generated by crossing aquaporin-2-Cre mice with S1PR1-floxed mice. Renal sodium excretion and arterial pressure were compared between wild-type (WT) and KO mice in response to high salt challenges and treatment of deoxycorticosterone acetate (DOCA)-salt. Protein levels of renal medullary S1PR1 were increased by 100% after high salt intake (HS), whereas DOCA treatment + HS blocked the increase of S1PR1 levels. Urinary sodium excretions in KO mice were decreased by 50% compared with WT mice after acute IV sodium loading (3.35±0.28 vs. 6.87±1.44 μmol/min/g kwt). The pressure natriuresis was impaired in KO mice compared with WT mice (4.22±0.61 vs. 10.76±1.30 μmole/min/g kwt). The chronic HS-induced positive sodium balance was enhanced in KO mice compared with WT mice (6.48±0.28 vs. 2.38±0.06 mmole/100g BW/24h). After 10-day DOCA-salt treatment, KO mice developed more severe hypertension than WT mice (systolic blood pressure 142±8 vs. 115±4 mmHg). The deletion of CD-S1PR1 reduced sodium excretion, promoted sodium retention, and accelerated DOCA-salt-induced salt-sensitive hypertension, suggesting that the CD-S1PR1 signaling is an important anti-hypertensive pathway by promoting sodium excretion and that impairment of renal medullary S1PR1 may represent a novel mechanism for salt-sensitive hypertension.